Stroke, Acute

Thrombolytic Therapy

Alteplase

Mortality

Alteplase in dose 0.9 mg/kg in acute ischemic patient with indications of thrombolytic therapy

Bu Ali Sina hospital , Mazandarn University of Medical Science

Thrombolysis Outcome in Ischemic Stroke

Evaluation of Thrombolytic Therapy in Acute Ischemic Stroke Outcome: A Cohort Study From North of Iran

evaluation of alteplase effect in morbidity of patient by using barthel index

mortality of patients who received alteplase

number of any adverse event of alteplase during study

number of fatal adverse event of alteplase during study

Athena Sharifi Razavi

Assistant Professor in neurology

Mazandaran University of Medical Sciences

it included 32 patients with acute ischemic stroke beyond the time of window (more than 6 hours) assigned to mechanical thrombectomy) plus the conventional treatment (Aspirin 150 mg and atorvastatin 40 mg).

it included 25 patients with acute ischemic stroke beyond the time of window (more than 6 hours) who received medical treatment (Aspirin 150 mg and atorvastatin 40 mg).

Acute Ischemic Stroke

Transfemoral a microcatheter with its distal end was positioned a few millimeters beyond the distal aspect of the clot, the guide wire was exchanged by Solitaire stent device. The device was held in place when 3 mm was out of the microcatheter. The microcatheter was slowly pulled back to deploy the TR or ST device over the clot.

thrombectomy

medical treatment (Asprin, statin, nootropic drug)

non intervention group

Ahmed El-Bassiony

Abdalla Khalil

Mechanical Thrombectomy in Acute Ischemic Stroke Beyond the Time of Window

Mechanical Thrombectomy in Acute Ischemic Stroke Beyond the Time of Window: Non Randomized Controlled Clinical Trial

1- Measuring the Modified Rankin Score (MRS) on day 90 (ranging from, 0 to 6, with higher scores indicating greater disability). Favorable outcome was defined as achieving functional independence (mRS of 0,1or 2) poor outcome was defined as MRS of 3-5.

2- Changes in National Institute of Health Stroke Scale (NIHSS) were also measured at baseline (pre-thrombectomy) and on day 90. Favorable outcome when the score decrease by 4 or more point of the score.

1-Estimate the number and percent of patients who have vascular recanalization according to thrombolysis in cerebral ischemia (TICI) score. TICI categories span from no perfusion (grade 0) to complete perfusion (grade 3). The "partial perfusion" category (grade 2) is defined as cases in which contrast passes the obstruction but with rates of entry and wash-out slower than normal and is subdivided into 2 subcategories, 2a and 2b. Successful vascular recanalization was defined as TICI grade 2b to 3.

2-estimate the number of patients who developed complication death (mRS=6) symptomatic intracerebral hemorrhage, and arterial dissection.

Eman M. Khedr

Professor of Neurology

Assiut University

Ain Shams University

Aswan University

Coagulation Factor Deficiency

Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Assiut University Children Hospital

Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Children Attending Assiut University Children Hospital ( a One Year Study)

data collected in sheet measuring type and level of deficient factor and measuring clotting tests(e.g. pt ,aptt)

intracranial hemorrhages/triglyceride

Thrombolysis Outcome in Ischemic Stroke

Mechanical Thrombectomy in Acute Ischemic Stroke Beyond the Time of Window

Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Assiut University Children Hospital

قاعدة بيانات الأعشاب الطبية الأكثر اكتمالا التي يدعمها العلم